Eltrombopag Olamine — supply status, manufacturers & alternatives

Eltrombopag Olamine

ATC B02BX05

In supply · Australia

Promacta

In supply · 🇦🇺 Australia · short in🇺🇸 US

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

In supply

no shortage substitution needed

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Active ingredient (INN)	Eltrombopag Olamine
Brand names	Promacta
ATC level 5	B02BX05
ATC level 4	B02BX

Controlled substance	No

Marketing-authorisation holders	AVKARE

Registrations on file	4

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

Global API supply base 🇺🇸 FDA Drug Master Files · active Type II

23 API manufacturers

Manufacturers with an active Type II Drug Master File — i.e. cleared to supply this active ingredient into the US market. A proxy for how concentrated the global manufacturing base is.

Low concentration risk

Synthimed Labs Private LTDZhejiang Hengkang Pharmaceutical CO LTDGranules India LTDHetero Drugs LTDMsn Laboratories Private LTDRaks Pharma PVT LTD+17 more

Manufacturing countries: India, China, Spain, Italy, Taiwan, Malaysia, Turkey · Source: FDA List of Drug Master Files

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders4 registrations · 1 MA holder

Product	Strength	Form	Market	MA holder	Status
Eltrombopag Olamine	12.5mg/1	tablet	🇺🇸 US	AVKARE	Active
Eltrombopag Olamine	25mg/1	tablet	🇺🇸 US	AVKARE	Active
Eltrombopag Olamine	50mg/1	tablet	🇺🇸 US	AVKARE	Active
Eltrombopag Olamine	75mg/1	tablet	🇺🇸 US	AVKARE	Active

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.